CHEMOCENTRYX INC's ticker is CCXI and the CUSIP is 16383L106. A total of 100 filers reported holding CHEMOCENTRYX INC in Q1 2018. The put-call ratio across all filers is 1.92 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2017 | $595,000 | -85.4% | 100,000 | -81.8% | 0.39% | -65.6% |
| Q3 2017 | $4,082,000 | +74.4% | 550,000 | +120.0% | 1.13% | -14.9% |
| Q2 2017 | $2,340,000 | +28.6% | 250,000 | 0.0% | 1.32% | +47.0% |
| Q1 2017 | $1,820,000 | -8.9% | 250,000 | -7.4% | 0.90% | -24.6% |
| Q4 2016 | $1,998,000 | +10.3% | 270,000 | -10.0% | 1.19% | +269.7% |
| Q3 2016 | $1,812,000 | +168.8% | 300,000 | +100.0% | 0.32% | +17.9% |
| Q2 2016 | $674,000 | – | 150,000 | – | 0.27% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Tri Locum Partners LP | 545,532 | $13,518,000 | 5.54% |
| Integral Health Asset Management, LLC | 574,029 | $14,224,000 | 2.93% |
| HealthCor Management, L.P. | 1,097,370 | $27,193,000 | 2.73% |
| Logos Global Management LP | 600,000 | $14,868,000 | 2.73% |
| Cormorant Asset Management, LP | 1,425,000 | $35,312,000 | 2.67% |
| Altium Capital Management LP | 160,000 | $3,965,000 | 1.59% |
| Cahill Wealth Management, LLC | 68,358 | $1,693,000 | 1.43% |
| Hood River Capital Management LLC | 1,336,776 | $33,125,000 | 1.32% |
| Sofinnova Investments, Inc. | 636,659 | $15,776,000 | 1.31% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 3,000 | $121,100,000 | 1.26% |